Aeterna Zentaris to Present at BioContact in Québec City
QUÉBEC CITY, Sept. 26, 2012 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its Senior Vice President and CFO, Dennis Turpin, CPA CA, will be presenting a corporate overview at BioContact on Wednesday, October 3, 2012, at 2 pm (Eastern), in the Grande-Allée Room of the Château Laurier Hotel in Québec City, Canada.
About Aeterna Zentaris
Aeterna Zentaris is an oncology and endocrinology drug development company currently investigating treatments for various unmet medical needs. The Company's pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. For more information please visit www.aezsinc.com.
Investor Relations Ginette Beaudet Vallières Investor Relations Coordinator (418) 652-8525 ext. 265 firstname.lastname@example.org
Media Relations Paul Burroughs Director of Communications (418) 652-8525 ext. 406 email@example.com
SOURCE: AETERNA ZENTARIS INC.
To view this news release in HTML formatting, please use the following URL: http://www.newswire.ca/en/releases/archive/September2012/26/c9570.html
CO: AETERNA ZENTARIS INC. ST: Quebec NI: BTC HEA MTC MED
-0- Sep/26/2012 11:30 GMT